| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 48.4307 | 43 |
| GSM780708 | Untreated after 4 days (C2_1) | 47.1079 | 37 |
| GSM780709 | Untreated after 4 days (C3_1) | 38.9553 | 4 |
| GSM780719 | Untreated after 4 days (C1_2) | 48.1907 | 42 |
| GSM780720 | Untreated after 4 days (C2_2) | 41.7813 | 12 |
| GSM780721 | Untreated after 4 days (C3_2) | 51.8585 | 54 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 43.866 | 21 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 43.0842 | 18 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 47.6571 | 40 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 48.537 | 43 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 44.3608 | 24 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 43.6996 | 21 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 46.5455 | 35 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 40.5735 | 8 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 42.9995 | 17 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 50.2428 | 49 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 48.0152 | 41 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 43.6195 | 20 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 48.2105 | 42 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 46.2314 | 33 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 48.3544 | 43 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 47.8752 | 41 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 47.95 | 41 |